BeOne Medicines registers Phase 1 trial of BG-T0050 in DLBCL and other B-cell cancersOct 21Weekly roundup, 5 itemsazacitidineBeiGene
BeOne Medicines registers two Phase 1 hepatic impairment PK studies for sonrotoclax and tacabrutidegOct 2Weekly roundup, 2 itemsBeiGenesonrotoclax
BeOne Medicines files STAR Market interim report, discloses R&D spend by product under US GAAPAug 26Quarterly updateBeiGene